Search results
Results from the WOW.Com Content Network
Psilocybin therapy is the use of psilocybin (the psychoactive ingredient in psilocybin mushrooms) in treating a range of mental health conditions, such as depression, anxiety, addictions, [1] obsessive compulsive disorder (OCD), and psychosis. [2] It is one of several forms of psychedelic therapy under study.
The psychedelic therapy method was initiated by Humphry Osmond and Abram Hoffer (with some influence from Al Hubbard) and replicated by Keith Ditman, [91] [92] and is more closely aligned to transpersonal psychology than to traditional psychoanalysis. [citation needed] Most recent research on psychedelic therapy has used psilocybin or ayahuasca ...
Over the last five years, research on psychedelic drugs as part of a therapy for mental conditions such as post-traumatic stress disorder, depression, anxiety and addiction has exploded.
Psychedelic therapy (or psychedelic-assisted therapy) refers to the proposed use of psychedelic drugs, such as psilocybin, MDMA, [note 2] LSD, and ayahuasca, to treat mental disorders. [ 58 ] [ 59 ] As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials ...
Psilocybin, a psychedelic component of magic mushrooms, is being studied for its potential use to treat depression at Ohio State University. Patients in clinical trials at Ohio State are given ...
The panel voted 10-to-1 against the first MDMA-based PTSD treatment, saying the benefits did not outweigh its risks, while nine members said the available data did not show its effectiveness in ...
The procedure for psychedelic therapy differs from that of therapies using conventional psychiatric medications. While conventional medications are usually taken without supervision at least once daily, in contemporary psychedelic therapy the drug is administered in a single session (or sometimes up to three sessions) in a therapeutic context. [62]
A meta-analysis of 43 research studies looking at psychedelics for use in mental health treatment found that 59% of the studies reported that at least one participant with a mild adverse effect of taking psychedelics; however, none of these situations required medical interventions. [27]